Overview
- Generics maker Zentiva plans a January 2026 launch of its liraglutide product Nevolat, with trade reports saying some German pharmacies received stock in mid‑December 2025.
- The reference price for the original was about €290 for five 3‑ml pens, and analysts expect generics to come in at half to roughly 70% lower.
- Liraglutide is an older, daily injection with more modest average weight loss than newer weekly options, so the price shift primarily affects that molecule.
- Current out‑of‑pocket costs in Germany typically range around €80–245 per month for Ozempic, €170–300 for Wegovy, and up to €500 for Mounjaro, depending on dose.
- Most statutory insurers do not reimburse these treatments, and Ozempic is often used off‑label for weight loss with patients paying the full cost.